Watch this space! The Bright Blog features our latest industry insights, team happenings, news, and the success stories where we helped our clients shine.
by Andrea Fenton Abbs
In a recent conversation with a new business contact, I shared what made Bright special, why we’re so optimistic about our future and why we excel at culture, employee retention, and repeat business. It was an easy conversation to have because it was authentic, and afterward I realized I had touched on many of the points in my “Building a Sustainable Bright Future” blog from January 2023. I thought it would be fun in this month’s blog to check back on those points and recap our best year ever!
Five ways Bright rocked 2023 and how we’ll keep it up into 2024 and beyond.
A medical device company’s post-approval study launch had been stalled for so long that continued FDA approval for their product was at risk. Furthermore, the company’s planned post-approval study, which aimed to monitor the long–term safety of their medical device, required a lengthy, five-year follow-up – and thus a large consumption of resources. Bright Research was brought in to help.
Bright’s Scott Brown and Dylan Lukes are back from #ISC2024, the world’s premier conference for stroke research and treatment. These two are passionate about clinical research and improving patient lives through statistically meaningful clinical studies.
Bright attends SIR 2024 in Salt Lake City.
As a CRO, Bright Research works closely with the U.S. Food and Drug Administration (FDA). In
Many thanks to the Minneapolis Regional Chamber for hosting a great #emergingleaders networking event highlighting AI in the workplace and
Marit Slawson, Jennifer Groben, Dylan Lukes, and Robin Solinsky were in Washington, DC catching up on the newest research on
Lights, Curtain, Alley Chats! Bravo to Medical Alley and Fredrikson & Byron, P.A. for bringing so much talent together in
A strong science-backed argument went a long way with the FDA.
A unique two-study strategy provides a path for putting an emergent-use medical device on the market.
Bright’s Scott Brown and Dylan Lukes are back from #ISC2024, the world’s premier conference for stroke
How Executing a New Literature Review Saved One Company 3 Years and $2 Million
Did you know February 11 is International Day of Women and Girls in Science? Today and every
Five ways Bright rocked 2023 and how we’ll keep it up into 2024 and beyond.
We share a few tips to help you ensure compliance with ClinicalTrials.gov requirements.